| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
0.9 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
1 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.0019 |
1 |